Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.39 USD | +0.68% | +2.21% | -25.65% |
05-13 | Sasol Limited Appoints Timothy John Cumming as Non-Executive Director, Effective 1 June 2024 | CI |
05-02 | Sasol Chief Financial Officer Hanre Rossouw to Step Down | MT |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The stock, which is currently worth 2024 to 0.63 times its sales, is clearly overvalued in comparison with peers.
- The company's share price in relation to its net book value makes it look relatively cheap.
- This company will be of major interest to investors in search of a high dividend stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-25.65% | 4.62B | - | ||
+0.22% | 75.55B | B | ||
+0.60% | 48.15B | A- | ||
+0.83% | 32.7B | C | ||
+11.16% | 18.21B | B | ||
+11.41% | 11.86B | A- | ||
-16.13% | 11.15B | B | ||
+1.43% | 11B | - | ||
-0.72% | 9.37B | A- | ||
-8.47% | 8.13B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SOL Stock
- SSL Stock
- Ratings Sasol Limited